Skip to content

Integer Holdings ITGR Other Markets — Sales

Other product segments

Cardiac Rhythm Management & Neuromodulation
$167.3M-1.9%

Similar metrics at other companies

Eastman Chemical logo
EMNOther Segments — Sales
$4.25M-5.6%
Envista Holdings Corporation logo
NVSTOther developed markets — Sales
$31.5M+3.6%
La-Z-Boy logo
LZBOther — Sales
$63.58M+33.8%
Kennametal logo
KMTOther — Sales
$52.72M-4.5%
Astronics logo
ATROOther — Sales
$5.62M-32.4%
VC
VCOther — Net Sales
$45M+21.6%

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$3.04B-27.0%
Enterprise value$4.41B-19.6%
P/E21.4×-32.8×
P/S1.6×-0.7×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Integer Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integer Holdings's other markets — sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integer Holdings's other markets — sales?
Integer Holdings (ITGR) reported other markets — sales of $9.58M in Q1 2026.
How has Integer Holdings's other markets — sales changed year-over-year?
Integer Holdings's other markets — sales decreased by 47.3% year-over-year, from $18.18M to $9.58M.
What is the long-term trend for Integer Holdings's other markets — sales?
Over 3 years (2022 to 2025), Integer Holdings's other markets — sales has grown at a -7.3% compound annual growth rate (CAGR), from $97.51M to $77.75M.
What does other markets — sales mean?
This metric measures the periodic revenue recognized from the sale of components and battery technologies specifically within the non-medical business segment. It tracks the commercial performance of products sold to industrial, energy, and defense clients, distinct from the company's core medical device operations. Analyzing these sales figures helps investors evaluate the segment's contribution to overall corporate revenue and its sensitivity to broader industrial market cycles.